May 1, 2023
Reporter, Health Care Inc. Writer
Hello, everyone! Welcome back to the newsletter that looks at all the ways money drives health care. Like how health systems could charge $75 for emails you send to your doctors. Don’t worry, your emails to me are on the house: bob.herman@statnews.com.

consolidation

Looking deeper into the Kaiser-Geisinger deal
Geisinger

Lisa Lake/Getty Images for Geisinger

There was a collective gasp last week when Kaiser Permanente announced it was acquiring Geisinger. Kaiser is putting its hospitals and all of Geisinger into a new organization called Risant Health, with the goal of adding at least another four health systems. 

Two of the biggest names, when people think of integrated health systems and coordinated care, combining? Just like that? Why would Geisinger need Kaiser’s help on anything, especially when it comes to “value-based care”?

The answer, like usual, has money at the core. Looking deeper at the transaction, it became clear Geisinger was actually stuck for years on a troubled path full of failed transactions, antitrust problems, and competition. Our new story today explains how the deal is raising the curtains to an even more aggressive era of consolidation among hospitals, doctors, and insurers — even among those considered to be sophisticated.

“What you’re seeing is the real changing nature of competition,” said Sachin Jain, CEO of SCAN Group, a health insurer in California, Arizona, and Texas that is in the process of its own merger with an insurer in Oregon. “Competition in health care has been really regional. It’s going to be increasingly national.”

Read the story to get more details about Geisinger’s litany of problems, why success is not guaranteed with Kaiser, potential targets for Risant, and what the antitrust angle is.


medicaid

A Medicaid pay raise for home care workers?

The federal government unveiled a beefy set of regulations last week that would more tightly regulate Medicaid and the cornucopia of state managed care rules. 

There’s a ton in these rules (you can read them here and here). One proposal has already rankled investors. CMS pitched the idea of having at least 80% of all Medicaid payments go toward the compensation of “direct care workers” who perform “homemaker services, home health aide services, and personal care services.” 

That would essentially cap the gross profit margin of home health companies at 20%. Publicly traded home care companies usually have gross margins well above that amount. CMS justified that threshold because other states have tried it, and since it’s focused on those workers and services, there aren’t really any major facility costs.

The stock price of Addus HomeCare, a large home health and hospice chain, plunged 27% Friday on the news. Addus is holding its earnings call today after the stock markets close, for those interested in hearing the industry’s first reaction to the rules.


hospitals

This is what happens when you don’t listen to voicemails

CMS is going to start cracking the whip more on hospitals that are not publishing their prices publicly — which, I feel the need to repeat, is required under federal law.

A couple weeks ago, CMS levied new fines on two hospitals: Kell West Regional Hospital in Texas and HCA’s Frisbie Memorial Hospital in New Hampshire. The situation at Frisbie was especially egregious: Not only did the hospital not post prices, it also did not submit a formal plan on how it would be compliant, and just flat-out ignored CMS, according to the federal notice outlining Frisbie’s penalty. CMS left three voicemails (three!), and the hospital just … never returned the federal government’s calls.

By the government’s own calculations, roughly 30% of hospitals still are not complying with the price transparency law. So, CMS has had enough and made some changes last week. 

Hospitals that have to submit a “corrective action plan” will have 90 days to come into compliance (previously, hospitals could propose their own timeline). Hospitals that also don’t submit a corrective action plan within 45 days will automatically get fined. Read the full set of changes.



insurance

The state of stop-loss coverage

It looks like getting insurance for health insurance is getting a bit costlier.

A new report from A.M. Best, a ratings agency for insurance companies, shows that premiums and claims have increased quite a bit for stop-loss insurance from 2014 through 2021. Stop-loss is the coverage that self-insured employers buy to protect themselves against expensive and unexpected medical claims from their workers. (I wrote last August about how much stop-loss coverage costs employers, and the different dynamics about who is buying stop-loss.)

Back in 2014, stop-loss insurers spent a little more than 74 cents of every $1 in premiums to cover these catastrophic claims. By 2021, that soared to 85 cents of every dollar, according to A.M. Best’s data. What gives? The main reason is there have just been more big-dollar claims. The main culprit? New, incredibly expensive drugs.

“Cell and gene therapies have been frequently named as the top cause of catastrophic claims,” A.M. Best analysts wrote in their report. “Regulators might see a need to intervene to avoid potential insolvencies given an enormous financial impact from these new drugs, especially on small and medium-sized groups.”


More around STAT
Check out more exclusive coverage with a STAT+ subscription
Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

Industry odds and ends

  • Bright Health Group started as a health insurance company, but it is now exiting the entire business. Bright really is on bankruptcy’s doormat.
  • ICYMI: Health insurance CEOs set a new record for pay in 2022. Read the story.
  • The arbitration process to settle out-of-network medical bill negotiations between providers and health insurers continues to be an absolute nightmare. A new report from the federal government said there were more than 110,000 disputes in arbitration in the last three months of 2022, which was “significantly more” than the feds thought would be submitted for a full year. Roughly 30% of the disputes should have never gone through arbitration and were ruled ineligible, which was an improvement from the 69% in the third quarter of 2022.
  • The next chapter in the case between the FTC and HCA/LCMC Health is out, and the hospitals are big mad. They wrote in a new filing that the FTC’s petition to halt their transaction “fails on the merits and the equities, and it does not even belong in this court.” (The FTC filed the case in D.C.’s federal district court; the hospitals say it belongs in Louisiana.)
  • Lots of earnings last week. TL;DR: Tenet, Universal Health Services, and Encompass Health followed HCA and reported higher volumes and beat earnings estimates; Humana and Centene remained profitable but had to explain why reserves are going down.
  • A bevy of earnings are on tap this week: Stryker (today), Surgery Partners (today), Community Health Systems (today), Pfizer (Tuesday), Zimmer Biomet (Tuesday), Oak Street Health (Tuesday), Premier (Tuesday), Pediatrix Medical Group (Tuesday), CVS Health (Wednesday), Evolent Health (Wednesday), Moderna (Thursday), Cardinal Health (Thursday), R1 RCM (Thursday), Select Medical (Thursday), AMN Healthcare (Thursday), Cigna (Friday). 

The Meme Ward

Health Care Inc. Meme - Issue 41


Thanks for reading! More next week.


Enjoying Health Care Inc.? Tell us about your experience
Continue reading the latest health & science news with the STAT app
Download on the App Store or get it on Google Play
STAT
STAT, 1 Exchange Place, Boston, MA
©2023, All Rights Reserved.